Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro

Journal of Psychopharmacology

Volumn 20, Issue 2, 2006, Pages 257-263

  Hayat, Shaista ^a   Williams, Robert J ^b   Rattray, Marcus ^b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT uptake; Amphetamine; COS 7; Forskolin; JAR cells; Neurotoxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; MALONIC ACID; MALONIC ACID DERIVATIVE; PSYCHEDELIC AGENT; SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN TRANSPORTER;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CERCOPITHECUS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NERVE CELL; RAT;

ANIMALS; CELL LINE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HALLUCINOGENS; MALONATES; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; RATS; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSFECTION;

EID: 33746787362     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106063273     Document Type: Article

References (32)

1. Azmitia E C, Murphy R B, Whitaker-Azmitia P M (1990) MDMA (ecstasy) effects on cultured neurons: evidence for Ca2(-)-dependent toxicity linked to release. Brain Res 510: 97-103
2. Battaglia G, Brooks B P, Kulsakdinun C, De Souza E B (1988) Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 149: 159-163
3. Blakely R D, Berson H E, Fremeau Jr R T, Caron M G, Peek M M, Prince H K, Bradley C C (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354: 66-70
4. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
5. Cool D R, Leibach F H, Bhalla V K, Mahesh V B, Ganapathy V (1991) Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J Biol Chem 266: 15750-15757
6. de la Torre R, Farré M (2004) Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 25: 505-508
7. de Silva J, French S J, Cheung N Y, Swinson A K, Bendotti C, Rattray M (2005) Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and pchloroamphetamine. Neurosci 134: 1363-1375
8. Esteban B, O'Shea E, Camarero J, Sanchez V, Green A R, Colado M I (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology (Berl) 154: 251-260
9. Green A R, Cross A J, Goodwin G M (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'). Psychopharmacol 119: 247-260
10. Green A R, Mechan A O, Elliott J M, O'Shea E, Colado M I (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 55: 463-508
11. Gudelsky G A, Yamamoto B K (2003) Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods Mol Med 79: 55-73
12. Hegadoren K M, Baker G B, Bourin M (1999) 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev 23: 539-553
13. Hirst W D, Price G W, Rattray M, Wilkin G P (1998) Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem Int 33: 11-22
14. Hrometz S L, Brown A W, Nichols D E, Sprague J E (2004) 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin- reuptake transporter, and monoamine oxidase-B. Neurosci Lett 367: 56-59
15. Kuhn D M, Geddes T J (2000) Molecular footprints of neurotoxic amphetamine action. Ann N Y Acad Sci 914: 92-103
16. Lyles J, Cadet J L (2003) Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Rev 42: 155-168
17. McKenna D J, Peroutka S J (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurochem 54:14-22
18. Malberg J E, Sabol K E, Seiden L S (1996) Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat J Pharmacol Exp Ther 278: 258-267
19. Paris J M, Cunningham K A (1992) Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Res Bull 28: 115-119
20. Rattray M (1991) Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem 26: 77-87
21. Ricaurte G A, Yuan J, McCann U D (2000) (-/-)3,4- Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiol 42: 5-10
22. Rudnick G, Wall S C (1992) The molecular mechanism of 'ecstasy' [3,4- methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89: 1817-1821
23. Saldana S N, Barker E L (2004) Temperature and 3,4- methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake. Neurosci Lett 354: 209-212
24. Sanchez V, Camarero J, Esteban B, Peter M J, Green A R, Colado M I (2001) The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br J Pharmacol 134: 46-57
25. Schmidt C J (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240: 1-7
26. Schmidt C J, Taylor V L (1988) Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur J Pharmacol 156: 121-131
27. Schmued L C (2003) Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 974: 127-133
28. Simantov R, Tauber M (1997) The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells FASEB J 11: 141-146
29. Sprague J E, Nichols D E (2005) Neurotoxicity of MDMA (ecstasy): beyond metabolism. Trends Pharmacol Sci 26: 59-60
30. Sprague J E, Everman S L, Nichols D E (1998) An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19: 427-441
31. Zaczek R, Culp S, De Souza E B (1990) Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration. J Neurochem 54: 195-204
32. Zaczek R, Culp S, Goldberg H, McCann D J, De Souza E B (1991) Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration. J Pharmacol Exp Ther 257: 820-829